Bridgepoint Group plc (LON:BPT) Declares Dividend of GBX 4.60

Bridgepoint Group plc (LON:BPT) declared a dividend on Friday, July 19th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, September 19th will be paid a dividend of GBX 4.60 ($0.06) per share on Monday, October 28th. This represents a dividend yield of 1.67%. The ex-dividend date of this dividend is Thursday, September 19th. This is a positive change from Bridgepoint Group’s previous dividend of $4.40. The official announcement can be accessed at this link.

Bridgepoint Group Stock Up 1.4 %

Shares of LON BPT opened at GBX 379 ($5.01) on Wednesday. The business has a 50-day moving average price of GBX 290.92 and a 200 day moving average price of GBX 256.79. The stock has a market cap of £3.11 billion, a PE ratio of 4,700.00, a price-to-earnings-growth ratio of 0.61 and a beta of 1.71. The company has a quick ratio of 3.60, a current ratio of 4.98 and a debt-to-equity ratio of 14.55. Bridgepoint Group has a 52-week low of GBX 168 ($2.22) and a 52-week high of GBX 391.20 ($5.17).

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Jefferies Financial Group restated a “buy” rating and set a GBX 310 ($4.10) target price on shares of Bridgepoint Group in a research report on Tuesday, July 9th. JPMorgan Chase & Co. upgraded shares of Bridgepoint Group to an “overweight” rating and increased their target price for the stock from GBX 259 ($3.42) to GBX 358 ($4.73) in a research note on Tuesday, August 13th.

About Bridgepoint Group

Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.